New Molecular Strategies to Cure Brain Tumors
Hassan Fathallah-Shaykh, MD
Arch Neurol. 1999;56:449-453.
Overall, malignant primary and metastatic brain tumors remain as lethal in the 1990s as they were in the 1970s. Just as the introduction of radiation therapy 2 decades ago added several months to survival time, numerous chemotherapeutic trials have demonstrated only limited efficacy. Fortunately, recent discoveries in molecular medicine have not only revolutionized our understanding of the events that lead to tumorigenesis, but they have created novel tools for targeting malignant cells. Novel treatment modalities are now being tested in pre–phase I animal models, while others are in different stages of clinical trials. The purpose of this review is to briefly summarize the emerging strategies of gene therapy, antiangiogenesis, immunotherapy, and targeting tumor cells.
From the Department of Neurology, University of Texas Southwestern Medical Center, Dallas.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(4):493-495.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Protease Pretreatment Increases the Efficacy of Adenovirus-mediated Gene Therapy for the Treatment of an Experimental Glioblastoma Model
Kuriyama et al.
Cancer Res. 2001;61:1805-1809.
ABSTRACT
| FULL TEXT
Gene Transfer of IFN-{gamma} into Established Brain Tumors Represses Growth by Antiangiogenesis
Fathallah-Shaykh et al.
J. Immunol. 2000;164:217-222.
ABSTRACT
| FULL TEXT
Neuro-oncology 1999
Rosenberg
Arch Neurol 1999;56:397-398.
FULL TEXT
|
